Adrianne Feldstein, MD, MS, maintains a clinical practice seeing patients at Kaiser Permanente Northwest (KPNW) and is a research physician in general public health, preventive medicine, and occupational medicine. In addition to her role as Investigator at CHR, she serves as the KPNW Assistant Medical Group Liaison for Research, and has joint appointments in the KPNW departments of Quality Management and Systems and Informatics. Dr. Feldstein’s position as liaison for research helps strengthen the ties between the clinical delivery system and the research center. It also provides a launching pad for her work in health care quality improvement, practice-based implementation, and translational research.

Her long-term interests are systems to improve the quality of care in prevention, injury, and chronic disease. Dr. Feldstein has led and participated in studies testing computerized reminder systems in health care practice and evaluating safety-related health care work practices. Dr. Feldstein heads several studies examining systems of care improvement and patient safety, particularly in the areas of treating osteoporosis, cardiovascular risk factors, and cancer screening. She has also examined how to change patient treatment, working on care reform in the areas of diabetes, hypertension, prenatal care, and tuberculosis.

Dr. Feldstein has been a KPNW physician and researcher for over 15 years. At KPNW, Dr. Feldstein was the chief of Occupational Medicine for seven years. Before that position, she held chief and medical director positions and transferred best practices in occupational medicine from KPNW to other organizations. Dr. Feldstein received her MD with distinction from the George Washington University School of Medicine and an MS in Public Health Nutrition from the Columbia University School of Public Health.

Current Studies:

	Evidence-Based Laboratory Medicine: Quality/Performance Evaluation in CKD—CKD LAB
	Focusing Implementation to Bring Effective Reminders—FIBER
	Forging Implementation of Cancer Screening Reminder Systems—FICSRS
	Using IT to Improve the Quality of CVD Prevention and Management—PRAVCO
	Weight in Secondary Prevention — WISP

Recently Completed Studies:

	Centers for Education and Research on Therapeutics—CERTS
	Effectiveness of Biophosphonates in a Real-World Setting—PAI
	Factors Associated with Gaps in Osteoporosis Treatment—Factors
	Financial Incentives in Depression — FIND
	Health and Economic Burden of Cardio-Metabolic Risk Factors
	Long-Term Safety and Efficacy of Oral Alendronate in Postmenopausal Women from the Fracture Intervention Trial—FLEX
	PREMIER Maintenance Trial Clinical Site-Weight Loss Maintenance
	Re-Fracture Intervention Trial — REFIT
	Screening and Treatment for Low Bone Mineral Density after Fracture — Merck Bone Density
	The Community-Based Rates of Psychiatric Events, Suicide-Related Events, Convulsions and Cardiovasular Events According to Patients' Body Mass Index: A Retrospective Cohort Study — BIRO
	The Refracture Intervention Trial Phase 2—REFIT 2

E-mail: Adrianne.C.Feldstein@kpchr.org